Combined Fasting Serum C4 and Primary Bile Acids From a Single Stool Sample to Diagnose Bile Acid Diarrhea

Priya Vijayvargiya; Michael Camilleri; Ann Taylor; Irene Busciglio; Edward V. Loftus; Leslie J. Donato

doi:10.1053/j.gastro.2020.07.001

Combined Fasting Serum C4 and Primary Bile Acids From a Single Stool Sample to Diagnose Bile Acid Diarrhea

Priya Vijayvargiya, Michael Camilleri, Ann Taylor, Irene Busciglio, Edward V. Loftus, Leslie J. Donato

Gastroenterology and Hepatology

Research output: Contribution to journal › Short survey › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1952-1954.e2
Journal	Gastroenterology
Volume	159
Issue number	5
DOIs	https://doi.org/10.1053/j.gastro.2020.07.001
State	Published - Nov 2020

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1053/j.gastro.2020.07.001

Cite this

@article{d2fd60578dce472e8489480db494393b,

title = "Combined Fasting Serum C4 and Primary Bile Acids From a Single Stool Sample to Diagnose Bile Acid Diarrhea",

author = "Priya Vijayvargiya and Michael Camilleri and Ann Taylor and Irene Busciglio and Loftus, {Edward V.} and Donato, {Leslie J.}",

note = "Funding Information: Conflict of interest These authors disclose the following: Michael Camilleri received a research grant from Allergan to study effects of eluxadoline in bile acid diarrhea. Edward V. Loftus Jr has provided consulting for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Eli Lilly, Genentech, Gilead, Janssen, Pfizer, Takeda, and UCB; research support from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Takeda, and UCB. The remaining authors disclose no conflicts. Funding Information: Funding This study was supported by grant R01-DK115950 from the National Institutes of Health to Michael Camilleri; by Department of Laboratory Medicine and Pathology (DLMP) Mayo Clinic intramural grant, 2018 DLMP Small Grant Program; and by 2018 American College of Gastroenterology Clinical Research Pilot Award to Priya Vijayvargiya. ",

year = "2020",

month = nov,

doi = "10.1053/j.gastro.2020.07.001",

language = "English (US)",

volume = "159",

pages = "1952--1954.e2",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - Combined Fasting Serum C4 and Primary Bile Acids From a Single Stool Sample to Diagnose Bile Acid Diarrhea

AU - Vijayvargiya, Priya

AU - Camilleri, Michael

AU - Taylor, Ann

AU - Busciglio, Irene

AU - Loftus, Edward V.

AU - Donato, Leslie J.

N1 - Funding Information: Conflict of interest These authors disclose the following: Michael Camilleri received a research grant from Allergan to study effects of eluxadoline in bile acid diarrhea. Edward V. Loftus Jr has provided consulting for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Eli Lilly, Genentech, Gilead, Janssen, Pfizer, Takeda, and UCB; research support from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Takeda, and UCB. The remaining authors disclose no conflicts. Funding Information: Funding This study was supported by grant R01-DK115950 from the National Institutes of Health to Michael Camilleri; by Department of Laboratory Medicine and Pathology (DLMP) Mayo Clinic intramural grant, 2018 DLMP Small Grant Program; and by 2018 American College of Gastroenterology Clinical Research Pilot Award to Priya Vijayvargiya.

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85096507241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096507241&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2020.07.001

DO - 10.1053/j.gastro.2020.07.001

M3 - Short survey

C2 - 32645316

AN - SCOPUS:85096507241

VL - 159

SP - 1952-1954.e2

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5

ER -